Incidence of adverse reactions to cyclosporine after liver transplantation is predicted by the first blood level
Daniel Azoulay, Antoinette Lemoine, Ashley Dennison, Jean Michel Gries, Isabelle Dolizy, Denis Castaing, Philippe Beaune, Henri Bismuth – 1 June 1993 – Despite the availability of whole‐blood cyclosporine assays, the different responses of individual patients to its administration after transplantation continue to pose clinical problems, particularly with respect to toxicity. Fifty‐seven recipients of first orthotopic liver transplants were studied between January 1992 and July 1992.